Mereo BioPharma Group plc (AIM:MPH)
London
· Delayed Price · Currency is GBP · Price in GBX 26.50
-0.50 (-1.85%)
At close: Dec 17, 2020
Mereo BioPharma Group Revenue
In the year 2025, Mereo BioPharma Group had annual revenue of $500.00K USD.
Revenue
$500.00K
Revenue Growth
n/a
P/S Ratio
88.10
Revenue / Employee
$12.82K
Employees
39
Market Cap
32.73M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Revolution Beauty Group | 119.55M |
| Celebrus Technologies | 23.66M |
| Gana Media Group | 2.05M |
| Manx Financial Group | 40.23M |
| Synectics | 68.10M |
| Christie Group | 67.03M |
| Clean Power Hydrogen | 4.00K |
Mereo BioPharma Group News
- 22 days ago - Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join – Contact Levi & Korsinsky - GlobeNewsWire
- 22 days ago - MREO DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO - GlobeNewsWire
- 22 days ago - MREO DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO - Newsfile Corp
- 22 days ago - MEREO LAWSUIT DEADLINE TODAY: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Regarding Their Rights - GlobeNewsWire
- 22 days ago - MREO FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026 - Business Wire
- 22 days ago - Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO - PRNewsWire
- 22 days ago - MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm - PRNewsWire
- 23 days ago - MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit - PRNewsWire